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Background: Aortic valve calcification (AVC) occurs during the early stages of aortic valve remodeling, frequently before the development of 
hemodynamic valve obstruction.
Limited data suggest that left ventricular hypertrophy, widely considered a compensatory consequence of aortic stenosis (AS), may be associated 
with calcific aortic valve disease (CAVD) even in the absence of AS. We evaluated the relationship between left ventricular mass and AVC in subjects 
with subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis (MESA).
Methods: A total of 5,042 subjects underwent cardiac magnetic resonance imaging and computed tomography (CT). The relationship of baseline 
percent of predicted left ventricular mass (LVM; standardized for gender, height, and weight) to the prevalence, severity, and incidence of AVC was 
determined by regression modeling.
Results: AVC was prevalent in 631 subjects at baseline CT (median score 55.9 Agatston units). An additional 227 subjects developed incident AVC 
at follow-up (median 3.1 years later). After adjustment for age, gender, body mass index, ethnicity, study site, socioeconomic factors, antihypertensive 
therapy, statin use, diabetes, smoking status, blood pressure, and cholesterol levels, LVM was positively associated with AVC (prevalence ratio=1.06 
[95%CI 1.03, 1.10]; p<0.0005; all results reported per 10% increase) and with AVC severity (risk difference = 1.15 [95%CI 1.09, 1.22]; p<0.0001) 
at baseline. In those without AVC at baseline, LVM was associated with the development of AVC (relative risk=1.17 [95%CI 1.05, 1.31]; p<0.005).
Conclusion: In the large, diverse MESA cohort, LVM was associated with prevalence and severity of AVC. An association between baseline LVM and 
incident AVC suggests that increased left ventricular mass may precede CAVD. Further study is needed to determine the mechanisms responsible for 
this association and evaluate its impact on patient outcomes.
